Articles > Popular publications > Business Wire press releases > January-March 2008 > Wednesday, March 26

Article: HemoBioTech Featured on Fox News.

Article from:
Business Wire
Article date:
March 26, 2008
Copyright

CEO Discusses HemoTech, Potentially the First Viable Human Blood Substitute

Interview featured on Fox Affiliates in New York, Dallas-Ft. Worth and Phoenix

DALLAS -- HemoBioTech (OTCBB: HMBT, www.hemobiotech.com), a developmental biopharmaceutical company focused on developing and commercializing potentially the first viable human blood substitute, was featured nationally on Fox News. HemoBioTech was featured on Fox affiliate stations in 13 markets, including New York, Dallas-Ft. Worth, Phoenix, Indianapolis, Nashville, Milwaukee and Austin, TX. The broadcast network currently leads the cable news market in the United States averaging 3.3 million viewers ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: HemoBioTech Expands Sponsored Research Agreement With ...
PR Newswire;  January 31, 2007 ;     700+ words ...HemoBioTech Is Developing HemoTech(TM), a Novel ... 31 /PRNewswire-FirstCall/ -- HemoBioTech, Inc. (BULLETIN BOARD: HMBT) announced ... expansion of the SRA agreement between HemoBioTech, Inc. and Texas Tech University and ...

Article: HemoBioTech Announces Expansion of Facilities.
PR Newswire;  February 1, 2007 ;     700+ words ...HemoBioTech is Developing HemoTech(TM), a Novel ... Feb. 1 /PRNewswire-FirstCall/ -- HemoBioTech, Inc. (BULLETIN BOARD: HMBT) announced ... Science Center in Lubbock, Texas. HemoBioTech has moved to The Arch in Dallas where ...

Article: HemoBioTech Announces Filing of Patent Application for ...
PR Newswire;  May 18, 2006 ;     700+ words ... ... May 18 /PRNewswire-FirstCall/ -- HemoBioTech, Inc. (BULLETIN BOARD: HMBT) announced ... novel chemically modified hemoglobin. HemoBioTech has a worldwide exclusive license to ... Arthur P. Bollon, Chairman and CEO of HemoBioTech. "There is a strong interest in new ...

Article: HemoBioTech, Inc. Updates Financial and Media News.
Business Wire;  January 29, 2008 ;     700+ words ... ... Highlights Recent Developments DALLAS -- HemoBioTech, Inc. (OTCBB: HMBT, http://www.hemobiotech.com) a biopharmaceutical company focused ... on recent media and financial news. * HemoBioTech, Inc. Participates in The McCuistion ...

Article: HemoBioTech to Present at 2007 MedTech Conference.
PR Newswire;  February 26, 2007 ;     700+ words ...HemoBioTech is Developing HemoTech(TM), a Novel ... 26 /PRNewswire-FirstCall/ -- HemoBioTech (BULLETIN BOARD: HMBT) announced ... Arthur P. Bollon, Chairman and CEO of HemoBioTech will make a presentation at the MedTech ...

Article: HemoBioTech Chairman and CEO, Dr. Arthur Bollon, to Give ...
Business Wire;  July 31, 2007 ;     700+ words ... ... Street, 48th Floor, Dallas DALLAS -- HemoBioTech (OTCBB: HMBT.OB) announced that ... 455-8953 for further information. HemoBioTech is developing what could be the world ... toxicity issues. On the other hand, the HemoBioTech strategy has been to identify and nullify ...

Article: Hemobiotech Announces Conversion of $750,000 Aggregate ...
PR Newswire;  August 17, 2005 ;     700+ words ... ... DALLAS, Aug. 17 /PRNewswire/ -- Hemobiotech, Inc. announced today that it has ... unpaid interest thereon into shares of Hemobiotech common stock, at a conversion price ... an aggregate of 765,132 shares of Hemobiotech common stock. Russell Cleveland, President ...

Article: HemoBioTech, Inc. Engages Regulus for FDA Services; ...
PR Newswire;  December 21, 2005 ;     700+ words ... ... 21 /PRNewswire-FirstCall/ -- HemoBioTech, Inc. (BULLETIN BOARD: HMBT) announced ... working with Regulus on their services for HemoBioTech. An initial foreign clinical study ... Chairman and Chief Executive Officer of HemoBioTech. Dr. Bollon further stated, "Our ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives